pCONUS 2 and pCONUS 2-HPC in the treatment of wide-necked intracranial aneurysms: Multicentre UK experience.

James YeomansSimon GattEzaz Habeeb MohamedRobert CrossleyPeter KestonDavid MinksNicholas DobbsAlexander MortimerJohnathan DownerAnand Sastry

Published in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2023)

pCONUS 2 and pCONUS 2-HPC have good short-term safety profiles. The use of pCONUS 2-HPC in the acute treatment of ruptured aneurysms with postprocedural SAPT is feasible. The devices have an intraprocedural complication rate of 4/65 (6.2%) across multiple UK centres, including a single death (1.5%).

Keyphrases

cross sectional
clinical trial
liver failure
intensive care unit
drug induced
replacement therapy
acute respiratory distress syndrome